Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1959 1
1961 1
1963 4
1964 1
1966 1
1968 1
1971 3
1972 1
1973 4
1974 3
1975 3
1976 6
1977 6
1978 4
1979 5
1980 1
1982 7
1983 6
1984 7
1985 6
1986 1
1987 5
1988 6
1989 3
1990 2
1991 3
1992 3
1993 4
1994 14
1995 11
1996 13
1997 19
1998 16
1999 29
2000 32
2001 38
2002 32
2003 30
2004 26
2005 37
2006 32
2007 43
2008 39
2009 30
2010 30
2011 34
2012 43
2013 42
2014 51
2015 53
2016 56
2017 77
2018 84
2019 86
2020 103
2021 92
2022 118
2023 86
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

1,334 results

Results by year

Filters applied: . Clear all
Page 1
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.
Minakata D, Fujiwara SI, Yokoyama D, Noguchi A, Aoe S, Oyama T, Koyama S, Murahashi R, Nakashima H, Hyodo K, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Nagayama T, Mashima K, Umino K, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kanda Y. Minakata D, et al. Among authors: kanda y. Br J Haematol. 2023 Mar;200(6):694-703. doi: 10.1111/bjh.18654. Epub 2023 Jan 20. Br J Haematol. 2023. PMID: 36661264 Review.
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: kanda y. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
[Preface].
Nishida M, Kanda Y. Nishida M, et al. Among authors: kanda y. Nihon Yakurigaku Zasshi. 2022;157(2):110. doi: 10.1254/fpj.21109. Nihon Yakurigaku Zasshi. 2022. PMID: 35228440 Japanese. No abstract available.
[Preface].
Kanda Y, Kurokawa J. Kanda Y, et al. Nihon Yakurigaku Zasshi. 2021;156(4):207. doi: 10.1254/fpj.21038. Nihon Yakurigaku Zasshi. 2021. PMID: 34193696 Japanese. No abstract available.
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Kohno S, Izumikawa K, Takazono T, Miyazaki T, Yoshida M, Kamei K, Ogawa K, Taniguchi S, Akashi K, Tateda K, Mukae H, Miyazaki Y, Okada F, Kanda Y, Kakeya H, Suzuki J, Kimura SI, Kishida M, Matsuda M, Niki Y. Kohno S, et al. Among authors: kanda y. J Infect Chemother. 2023 Feb;29(2):163-170. doi: 10.1016/j.jiac.2022.10.010. Epub 2022 Oct 25. J Infect Chemother. 2023. PMID: 36307059 Free article. Clinical Trial.
[Overview].
Kanda Y. Kanda Y. Rinsho Ketsueki. 2020;61(4):368. doi: 10.11406/rinketsu.61.368. Rinsho Ketsueki. 2020. PMID: 32378582 Japanese. No abstract available.
Drug repurposing for the treatment of COVID-19.
Kato Y, Nishiyama K, Nishimura A, Noda T, Okabe K, Kusakabe T, Kanda Y, Nishida M. Kato Y, et al. Among authors: kanda y. J Pharmacol Sci. 2022 Jul;149(3):108-114. doi: 10.1016/j.jphs.2022.04.007. Epub 2022 Apr 25. J Pharmacol Sci. 2022. PMID: 35641023 Free PMC article. Review.
Two-Phase Synthesis of Taxol.
Kanda Y, Nakamura H, Umemiya S, Puthukanoori RK, Murthy Appala VR, Gaddamanugu GK, Paraselli BR, Baran PS. Kanda Y, et al. J Am Chem Soc. 2020 Jun 10;142(23):10526-10533. doi: 10.1021/jacs.0c03592. Epub 2020 May 29. J Am Chem Soc. 2020. PMID: 32406238 Free PMC article.
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models.
Urano E, Itoh Y, Suzuki T, Sasaki T, Kishikawa JI, Akamatsu K, Higuchi Y, Sakai Y, Okamura T, Mitoma S, Sugihara F, Takada A, Kimura M, Nakao S, Hirose M, Sasaki T, Koketsu R, Tsuji S, Yanagida S, Shioda T, Hara E, Matoba S, Matsuura Y, Kanda Y, Arase H, Okada M, Takagi J, Kato T, Hoshino A, Yasutomi Y, Saito A, Okamoto T. Urano E, et al. Among authors: kanda y. Sci Transl Med. 2023 Aug 30;15(711):eadi2623. doi: 10.1126/scitranslmed.adi2623. Epub 2023 Aug 30. Sci Transl Med. 2023. PMID: 37647387
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K, Yanagiya R, Miyatake Y, Carreras J, Higuchi H, Murayama H, Ishida T, Ito A, Iida S, Fukuhara N, Harigae H, Fujioka Y, Takahashi N, Wada H, Ishida F, Nakazawa H, Ishihara R, Murakami Y, Tagawa H, Matsuura T, Nakagawa S, Iwabuchi S, Hashimoto S, Imadome KI, Nakamura N, Ishizawa K, Kanda Y, Ando K, Kotani A. Kameda K, et al. Among authors: kanda y. Blood. 2023 Jul 27;142(4):352-364. doi: 10.1182/blood.2022018597. Blood. 2023. PMID: 37146246
1,334 results